Medicinal preparation (Daclatasvir)
This tender has expired
The submission deadline for this tender has passed. It is no longer accepting bids.
About This Opportunity
This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in Russia, Europe, this opportunity is open to firms and consortiums, with an estimated budget of RUB 290,400. Proposals must be submitted before June 25, 2026.
Published through GosPlaN Russia, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.
Description
Original language: RussianThis tender, originating from Russia and published on gosplan_ru, concerns the procurement of the pharmaceutical drug Daclatasvir. This is a state-funded procurement initiative aimed at acquiring a specific medication. Daclatasvir is an antiviral medication used primarily for the treatment of Hepatitis C. Suppliers bidding for this tender are expected to provide Daclatasvir that meets stringent pharmaceutical quality standards, including compliance with Good Manufacturing Practices (GMP) and relevant pharmacopoeial monographs (e.g., Russian Pharmacopoeia, USP, EP). The tender will likely specify the required dosage forms (e.g., tablets), strengths, packaging sizes, and total quantities. Bidders must demonstrate the authenticity and origin of the drug, providing necessary registration certificates, marketing authorizations from Russian regulatory authorities (Roszdravnadzor), and quality control documentation. Delivery to designated healthcare facilities within Russia within specified timeframes will also be a key requirement.
This procurement is vital for ensuring patient access to essential Hepatitis C treatment.
Data provenance
This notice is sourced from GosPlaN Russia and was originally published on June 11, 2026. Last refreshed 18 days ago. Original language: Russian. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About 5907042643
5907042643 has issued 58 procurement notices on BidsFactory, including 6 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Education & Training. All notices are published for Russia. Notices are distributed via GosPlaN Russia. Most recent publication: June 16, 2026.
Frequently asked questions about this tender
When does this tender close?
The submission deadline is June 25, 2026. Proposals must be received by the contracting authority before that date.
Who is the contracting authority?
This notice was issued by 5907042643 in Russia. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is RUB 290,400 - RUB 290,400. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Russia. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit GosPlaN Russia to access the full notice, required documents, and submission instructions provided by the contracting authority.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.